ArticlePharmacoEconomics - open2022

Health State Utilities for Adverse Events Associated with Chimeric Antigen Receptor T-Cell Therapy in Large B-Cell Lymphoma.

Timothy A Howell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.